This inventor holds 1 USPTO granted patent and 5 published patent applications, plus 1 CIPO patent. Top assignees: Memorial Sloan Kettering Cancer Center, Tri-Institutional Therapeutics Discovery Institute. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 621 
1 out of 11 Years Active: 2026
Title: Danny Nejad Khalil: Inventor in Therapeutic Discovery
Introduction
Danny Nejad Khalil is an inventor based in New York, New York. His patent work includes research into CD40-binding molecules and their potential uses.
Latest Patents
Khalil is associated with 1 patent: “CD40 Binding Molecules and Uses Thereof.” The patent concerns molecules that bind to CD40 and their applications.
Career Highlights
Khalil has worked with the Tri-Institutional Therapeutics Discovery Institute and Memorial Sloan Kettering Cancer Center. These organizations are associated with therapeutic discovery and cancer research.
Collaborations
Khalil’s listed coworkers include Jedd David Wolchok and Taha Merghoub, researchers whose work is connected to cancer research and immunotherapy.
Conclusion
Danny Nejad Khalil’s patent on CD40-binding molecules reflects his involvement in therapeutic discovery and research connected with cancer-focused institutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile